Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide notice announces updates to NIH websites and says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T15:17:22.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:00:41.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:00:36.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page instead of showing the study record details. Access to the study information is blocked, leaving only site chrome and footer visible.
    Difference
    18%
    Check dated 2026-09-20T20:36:11.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a minor update to the page version and likely routine fixes or tweaks.
    Difference
    0.1%
    Check dated 2026-08-30T21:52:56.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.4 to v3.6.5, indicating a deployment of the front-end platform; this appears to be an internal update rather than a change to study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-08-09T08:29:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.